Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Solon Eiendom ASA : Primary insider notification


Posted on: 22 Jan 18

(Oslo, Norway, February 01, 2018)  Solon Eiendom ASA Board Member Edvin Austbø (through his wholly owned company Alden AS) has today bought 45,000 shares in Solon Eiendom ASA at a price of NOK 21.8681 per share.

Following this transaction Edvin Austbø through Alden AS holds 6,169,588 shares, equalling 11.54% of the total share capital and votes of the Company.

This information is subject to the disclosure requirements set out in section 5-12 of the Norwegian Securities Trading Act.

Further information
Andreas Martinussen, Chief Executive Officer, Solon Eiendom ASA
Tel:       +47 400 00 405,            email: am@soloneiendom.no

Scott Danielsen, Chief Financial Officer, Solon Eiendom ASA
Tel:       +47 952 55 620,            email: sd@soloneiendom.no

About Solon Eiendom
Solon Eiendom is a Norwegian residential real estate development company focusing on the Oslo and Akershus region. Solon Eiendom was established in 2006 by founder Simen Thorsen and investor Tore Aksel Voldberg.

Attachments:

http://www.globenewswire.com/NewsRoom/AttachmentNg/ce1a4996-6459-48a2-8cc2-3b367bbf5489

GlobeNewswire
globenewswire.com

Last updated on: 02/02/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.